S&P・Nasdaq 本質的価値 お問い合わせ
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← 全銘柄に戻る

Vertex Pharmaceuticals Incorporated VRTX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
84/100
5/7 Pass
SharesGrow Intrinsic Value
$645.55
+45.3%
Analyst Price Target
$549.73
+23.7%

合計 50 件の最近のインサイダー取引記録が記録されています Vertex Pharmaceuticals Incorporated (VRTX), 内訳は 1 件の買い および 48 件の売り. インサイダー買い総額は RSU アワード インサイダー売り総額は $50.44M.

最近活動のある主要インサイダーには Liu Joy, Bozic Carmen, Mckechnie Duncan. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.

インサイダー取引記録 — VRTX

日付 氏名 役職 取引種別 株数 平均価格 価値 保有株数
2026-04-01 Liu Joy EVP and Chief Legal Officer 情報に基づく売り 978 $449.17 $439.29K 21,833
2026-03-27 Bozic Carmen EVP and CMO 情報に基づく売り 2,329 $450.95 $1.05M 33,076
2026-03-13 Bozic Carmen EVP and CMO 情報に基づく売り 2,329 $481.79 $1.12M 35,405
2026-03-11 Mckechnie Duncan EVP, Chief Commercial Officer 情報に基づく売り 2,633 $498.42 $1.31M 12,489
2026-03-04 Mckechnie Duncan EVP, Chief Commercial Officer 情報に基づく売り 2,437 $475.30 $1.16M 15,122
2026-03-02 Liu Joy EVP and Chief Legal Officer 情報に基づく売り 892 $495.96 $442.4K 22,811
2026-03-01 Liu Joy EVP and Chief Legal Officer 不明 7,044 $155.57 $1.1M -
2026-02-27 Kewalramani Reshma CEO & President 情報に基づく売り 1,725 $496.95 $857.24K 98,278
2026-02-27 Bozic Carmen EVP and CMO 情報に基づく売り 2,329 $480.31 $1.12M 37,734
2026-02-26 Ambrose Kristen SVP & Chief Accounting Officer 情報に基づく売り 357 $483.36 $172.56K 6,624
2026-02-25 Sachdev Amit EVP Chief Patient & Ext Af Off 情報に基づく売り 1,846 $486.35 $897.8K 55,570
2026-02-25 Biller Jonathan EVP and Chief Legal Officer 情報に基づく売り 945 $486.35 $459.6K 13,659
2026-02-25 Tatsis Ourania EVP, Chief Reg. & Quality Off. 情報に基づく売り 260 $486.35 $126.45K 46,763
2026-02-25 Ambrose Kristen SVP & Chief Accounting Officer 情報に基づく売り 223 $486.35 $108.46K 6,981
2026-02-25 Atkinson Edward Morrow Iii EVP, Chief Technical Ops. Off. 情報に基づく売り 668 $486.35 $324.88K 18,432
2026-02-25 Mckechnie Duncan EVP, Chief Commercial Officer 情報に基づく売り 2,410 $489.00 $1.18M 17,559
2026-02-25 Bunnage Mark E. EVP, Chief Scientific Officer 情報に基づく売り 620 $486.35 $301.54K 7,284
2026-02-24 Wagner Charles F Jr EVP, Co & Fo RSU 源泉徴収 1,744 $485.11 $846.03K 47,042
2026-02-24 Leiden Jeffrey M Executive Chairman RSU 源泉徴収 3,547 $485.11 $1.72M 34,797
2026-02-24 Sachdev Amit EVP Chief Patient & Ext Af Off RSU 源泉徴収 1,518 $485.11 $736.4K 57,416
2026-02-24 Kewalramani Reshma CEO & President RSU 源泉徴収 4,981 $485.11 $2.42M 138,278
2026-02-24 Biller Jonathan EVP and Chief Legal Officer RSU 源泉徴収 1,144 $485.11 $554.97K 14,604
2026-02-24 Tatsis Ourania EVP, Chief Reg. & Quality Off. RSU 源泉徴収 1,627 $485.11 $789.27K 47,023
2026-02-24 Bozic Carmen EVP and CMO RSU 源泉徴収 1,453 $485.11 $704.86K 40,063
2026-02-24 Ambrose Kristen SVP & Chief Accounting Officer RSU 源泉徴収 546 $485.11 $264.87K 7,204
2026-02-24 Atkinson Edward Morrow Iii EVP, Chief Technical Ops. Off. RSU 源泉徴収 1,627 $485.11 $789.27K 19,100
2026-02-24 Mckechnie Duncan EVP, Chief Commercial Officer RSU 源泉徴収 873 $485.11 $423.5K 22,469
2026-02-24 Bunnage Mark E. EVP, Chief Scientific Officer RSU 源泉徴収 582 $485.11 $282.33K 7,904
2026-02-19 Sachdev Amit EVP Chief Patient & Ext Af Off オプション行使（売却） 25,026 $187.53 $4.69M -
2026-02-18 Leiden Jeffrey M Executive Chairman RSU 源泉徴収 2,964 $483.75 $1.43M 38,344
2026-02-18 Biller Jonathan EVP and Chief Legal Officer 情報に基づく売り 1,244 $473.68 $589.26K 15,748
2026-02-18 Tatsis Ourania EVP, Chief Reg. & Quality Off. 情報に基づく売り 368 $473.68 $174.31K 48,650
2026-02-18 Ambrose Kristen SVP & Chief Accounting Officer 情報に基づく売り 638 $473.68 $302.21K 7,750
2026-02-18 Atkinson Edward Morrow Iii EVP, Chief Technical Ops. Off. 情報に基づく売り 817 $473.68 $387K 20,727
2026-02-18 Bunnage Mark E. EVP, Chief Scientific Officer 情報に基づく売り 1,182 $473.68 $559.89K 8,486
2026-02-17 Wagner Charles F Jr EVP, Co & Fo RSU 源泉徴収 2,294 $483.75 $1.11M 48,786
2026-02-17 Leiden Jeffrey M Executive Chairman RSU 付与（制限付株式） 8,269 - - 41,308
2026-02-17 Sachdev Amit EVP Chief Patient & Ext Af Off RSU 源泉徴収 2,140 $483.75 $1.04M 69,042
2026-02-17 Kewalramani Reshma CEO & President RSU 源泉徴収 6,554 $483.75 $3.17M 143,259
2026-02-17 Biller Jonathan EVP and Chief Legal Officer 情報に基づく売り 2,476 $489.46 $1.21M 16,992
2026-02-17 Tatsis Ourania EVP, Chief Reg. & Quality Off. 情報に基づく売り 609 $489.46 $298.08K 49,018
2026-02-17 Bozic Carmen EVP and CMO RSU 源泉徴収 1,912 $483.75 $924.93K 41,516
2026-02-17 Ambrose Kristen SVP & Chief Accounting Officer 情報に基づく売り 1,557 $489.46 $762.09K 8,388
2026-02-17 Atkinson Edward Morrow Iii EVP, Chief Technical Ops. Off. 情報に基づく売り 2,031 $489.46 $994.09K 21,544
2026-02-17 Mckechnie Duncan EVP, Chief Commercial Officer RSU 源泉徴収 1,148 $483.75 $555.35K 23,342
2026-02-17 Bunnage Mark E. EVP, Chief Scientific Officer 情報に基づく売り 2,437 $489.46 $1.19M 9,668
2026-02-13 Wagner Charles F Jr EVP, Co & Fo RSU 源泉徴収 4,565 $487.76 $2.23M 43,715
2026-02-13 Sachdev Amit EVP Chief Patient & Ext Af Off RSU 源泉徴収 3,548 $487.76 $1.73M 65,393
2026-02-13 Bhatia Sangeeta N. Director 情報に基づく売り 266 $500.00 $133K 4,299
2026-02-13 Kewalramani Reshma CEO & President RSU 源泉徴収 13,041 $487.76 $6.36M 133,487
■ 情報付き — 公開市場取引（最も重要） ■ 情報なし（買い） — 報酬・オプション行使・転換 ■ 情報なし（売り） — 源泉徴収・付与売却 ■ 中立 — 贈与・信託・失効

他のユーザーも閲覧

REGN
REGN
Regeneron Pharmaceuticals, Inc.
$755.51
+1.21%
 ALNY
ALNY
Alnylam Pharmaceuticals, Inc.
$339.41
+1.92%
 SGEN
SGEN
Seagen Inc.
$228.74
-0.07%
 BNTX
BNTX
BioNTech SE
$98.41
+1.77%
 MRNA
MRNA
Moderna, Inc.
$52.84
+4.26%
 MDGL
MDGL
Madrigal Pharmaceuticals, Inc.
$524.99
-0.13%
 BMRN
BMRN
BioMarin Pharmaceutical Inc.
$55.47
+1.08%
 KRYS
KRYS
Krystal Biotech, Inc.
$270.00
+0.97%
お問い合わせ
🎓
SharesGrow アカデミー
本質的価値の計算と割安株の見つけ方を学ぶ。
毎週のライブセッション
📧 [email protected]
📞 +65 8912 8000
メッセージを送る